These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8358347)

  • 1. In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody.
    Sakahara H; Saga T; Endo K; Hattori N; Hosono M; Kobayashi H; Shirato M; Yamamuro T; Toyama S; Arano Y
    Nucl Med Biol; 1993 Jul; 20(5):617-23. PubMed ID: 8358347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
    Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies.
    Sakahara H; Endo K; Koizumi M; Nakashima T; Kunimatsu M; Watanabe Y; Kawamura Y; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1988 Feb; 29(2):235-40. PubMed ID: 3162255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.
    Sakahara H; Endo K; Nakashima T; Koizumi M; Kunimatsu M; Kawamura Y; Ohta H; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1987 Mar; 28(3):342-8. PubMed ID: 3469333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity.
    Kobayashi H; Sato N; Saga T; Nakamoto Y; Ishimori T; Toyama S; Togashi K; Konishi J; Brechbiel MW
    Eur J Nucl Med; 2000 Sep; 27(9):1334-9. PubMed ID: 11007515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
    Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
    J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo radiolocalization of antiosteogenic sarcoma monoclonal antibodies in osteogenic sarcoma xenografts.
    Nakamura T; Sakahara H; Hosoi S; Yamamuro T; Higashi S; Mikawa H; Endo K; Toyama S
    Cancer Res; 1984 May; 44(5):2078-83. PubMed ID: 6585270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeating the avidin "chase" markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity.
    Kobayashi H; Sakahara H; Endo K; Yao ZS; Toyama S; Konishi J
    Eur J Cancer; 1995 Sep; 31A(10):1689-96. PubMed ID: 7488426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.
    Gooden CS; Snook DE; Maraveyas A; Rowlinson-Busza G; Peters AM; Epenetos AA
    J Nucl Med; 1995 May; 36(5):842-9. PubMed ID: 7738662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
    Kobayashi H; Sakahara H; Saga T; Hosono M; Shirato M; Kanda H; Ishibashi K; Watanabe T; Endo K; Ishiwata I
    Cancer Immunol Immunother; 1993 Aug; 37(3):143-9. PubMed ID: 7687520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4.
    Maeda M; Shoji M; Kawagoshi T; Futatsuya R; Honda T; Brady LW
    Cancer; 1994 Feb; 73(3 Suppl):800-7. PubMed ID: 8306263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoconjugate stability in vivo measured by label release from 125I or 99mTc-antibody coated cells kept in intraperitoneal diffusion chambers in mice.
    Fjeld J; Brorson B; Martinussen GK; Benestad H; Nustad K
    Acta Oncol; 1993; 32(7-8):873-6. PubMed ID: 8305239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of sarcoma xenografts in nude mice with indium-111-labeled monoclonal antibodies.
    Chao TC; Blend MJ; Lopes AD; Atcher RW; Das Gupta TK; Greager JA
    J Surg Res; 1993 Jul; 55(1):38-43. PubMed ID: 8412080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.